281 related articles for article (PubMed ID: 2179855)
1. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
[TBL] [Abstract][Full Text] [Related]
2. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
3. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB).
Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL
Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.
Shapiro ED; Berg AT
Pediatrics; 1990 Apr; 85(4 Pt 2):643-7. PubMed ID: 2179854
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
[TBL] [Abstract][Full Text] [Related]
9. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
Peltola H; Käyhty H; Sivonen A; Mäkelä H
Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
[TBL] [Abstract][Full Text] [Related]
10. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate).
Gray BM
Pediatrics; 1990 Apr; 85(4 Pt 2):694-7. PubMed ID: 2107521
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.
Ahonkhai VI; Lukacs LJ; Jonas LC; Matthews H; Vella PP; Ellis RW; Staub JM; Dolan KT; Rusk CM; Calandra GB
Pediatrics; 1990 Apr; 85(4 Pt 2):676-81. PubMed ID: 2107518
[TBL] [Abstract][Full Text] [Related]
12. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
13. Passive immunization for infection with Haemophilus influenzae type b.
Santosham M; Reid R; Letson GW; Wolff MC; Siber G
Pediatrics; 1990 Apr; 85(4 Pt 2):662-6. PubMed ID: 2179857
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.
Steinhoff MC; Auerbach BS; Nelson KE; Vlahov D; Becker RL; Graham NM; Schwartz DH; Lucas AH; Chaisson RE
N Engl J Med; 1991 Dec; 325(26):1837-42. PubMed ID: 1683682
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
Käyhty H; Peltola H; Eskola J
Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
[TBL] [Abstract][Full Text] [Related]
17. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
Adderson EE; Chisholm N; Halperin SA
Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
[TBL] [Abstract][Full Text] [Related]
18. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
19. Conjugated Haemophilus influenzae type b vaccine.
Med Lett Drugs Ther; 1988 Apr; 30(764):47-8. PubMed ID: 3258400
[No Abstract] [Full Text] [Related]
20. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]